Related Experiment Video

Updated: May 11, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

Clinical response to antibiotics among children with bloody diarrhea

Priya Sreenivasan, Zinia T Nujum, K K Purushothaman

    Indian Pediatrics
    |May 18, 2013
    PubMed

    Insights

    Cotrimoxazole showed better outcomes for children with bloody diarrhea compared to other antibiotics. This suggests older antibiotics may be more effective in certain clinical situations for pediatric bloody diarrhea treatment.

    Area of Science:

    • Pediatric infectious diseases
    • Clinical pharmacology
    • Antimicrobial resistance

    Background:

    • The World Health Organization (WHO) recommends ciprofloxacin for bloody diarrhea.
    • A retrospective analysis of 100 pediatric patients admitted between 2006-2010 with bloody diarrhea was conducted.
    • Antibiotic treatment responses were evaluated.

    Discussion:

    • Cotrimoxazole (n=55) demonstrated superior outcomes compared to other antibiotics (n=45).
    • Patients receiving cotrimoxazole had a higher likelihood of improved appetite and activity within 48 hours.
    • Key benefits included shorter hospitalization (<3 days), faster blood disappearance (≤5 days), and reduced need for a second antibiotic.

    Key Insights:

    • Cotrimoxazole offers significant clinical advantages in treating pediatric bloody diarrhea.
    • Early recovery markers such as appetite, activity, and symptom resolution are improved with cotrimoxazole.
    • Reduced hospitalization duration and need for additional antibiotic courses were observed.

    Outlook:

    • Consideration of older broad-spectrum antibiotics like cotrimoxazole is warranted for pediatric bloody diarrhea.
    • Further research into the comparative efficacy of different antibiotic classes for specific pediatric infections is recommended.
    • This study highlights the potential for optimizing empirical antibiotic strategies in pediatric care.

    More Related Videos

    Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment08:33

    Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment

    Published on: November 17, 2018

    Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates08:32

    Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

    Published on: February 17, 2023

    Related Concept Videos

    Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

    Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

    Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
    Bacterial Gastroenteritis01:18

    Bacterial Gastroenteritis

    Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
    Stringent Response in E. coli01:23

    Stringent Response in E. coli

    Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
    Cholera01:25

    Cholera

    Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
    Inflammatory Bowel Disease IV: Clinical Manifestations01:20

    Inflammatory Bowel Disease IV: Clinical Manifestations

    Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...